Cellular immune function study in an ovarian cancer-prone kindred.
作者信息
Schuelke G S, Lynch H T, Lynch J F, Chaperon E A, Recabaren J A, Grabner B, Albano W A
出版信息
Br J Cancer. 1982 Oct;46(4):687-93. doi: 10.1038/bjc.1982.256.
Abstract
摘要
相似文献
1
Cellular immune function study in an ovarian cancer-prone kindred.一个卵巢癌高发家系的细胞免疫功能研究
Br J Cancer. 1982 Oct;46(4):687-93. doi: 10.1038/bjc.1982.256.
2
Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study.卵巢癌患者多次注射未偶联的嵌合单克隆抗体MOv18后的细胞和体液反应：一项初步研究。
J Cancer Res Clin Oncol. 2002 Sep;128(9):484-92. doi: 10.1007/s00432-002-0348-z. Epub 2002 Aug 23.
3
[Cellular immune function of patients with ovarian cancer before and after cancer therapy].[卵巢癌患者癌症治疗前后的细胞免疫功能]
Nihon Gan Chiryo Gakkai Shi. 1985 Jul 20;20(6):1146-62.
4
Activated cellular immunity in ovarian carcinoma patients.卵巢癌患者的活化细胞免疫
Am J Obstet Gynecol. 1994 Oct;171(4):1159-60. doi: 10.1016/0002-9378(94)90057-4.
5
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer.卵巢癌患者腹腔及血液中的淋巴细胞细胞毒性
Obstet Gynecol. 1984 Nov;64(5):708-14.
6
IL-1 inhibitor in ascites fluids from ovarian cancer patients.卵巢癌患者腹水中的白细胞介素-1抑制剂
Nihon Sanka Fujinka Gakkai Zasshi. 1987 Dec;39(12):2197-8.
7
8
Demonstration of cell-mediated and humoral antibodies in patients with malignant breast and ovary-tumours.恶性乳腺和卵巢肿瘤患者细胞介导抗体和体液抗体的显示。
Acta Eur Fertil. 1973 Jun;4(2):75-7.
9
Tumour-associated immune responses and isolated carcinoembryonic antigen and alpha feto-protein levels related to survival in ovarian cancer patients.肿瘤相关免疫反应以及与卵巢癌患者生存率相关的孤立癌胚抗原和甲胎蛋白水平。
Br J Cancer. 1976 Apr;33(4):363-9. doi: 10.1038/bjc.1976.60.
10
Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis.
Bull Cancer. 1993 Feb;80(2):121-34.
本文引用的文献
1
Familial excess of cancer of the ovary and other anatomic sites.卵巢癌及其他解剖部位癌症的家族性高发。
JAMA. 1981 Jan 16;245(3):261-4.
2
Inhibition of effector cell functions in natural killer cell activity (NK) and antibody-dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera.正常血清和癌血清对小鼠自然杀伤细胞活性（NK）及抗体依赖性细胞毒性（ADCC）中效应细胞功能的抑制作用。
Int J Cancer. 1980 May 15;25(5):667-77. doi: 10.1002/ijc.2910250518.
3
4
Low serum IgA in a familial ovarian cancer aggregate.家族性卵巢癌群体中血清IgA水平较低。
Cancer Genet Cytogenet. 1982 Jul;6(3):231-6. doi: 10.1016/0165-4608(82)90060-7.
5
Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors.腹水型卵巢肿瘤患者外周血单核细胞和肿瘤相关巨噬细胞对肿瘤细胞的细胞毒性作用。
J Natl Cancer Inst. 1980 Jun;64(6):1307-15. doi: 10.1093/jnci/64.6.1307.
6
7
Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.从人卵巢腹水肿瘤中分离出的淋巴细胞的自然杀伤活性。
Int J Cancer. 1980 May 15;25(5):573-82. doi: 10.1002/ijc.2910250505.
8
Serum concentrations of G, A, and M immunoglobulins in patients with carcinoma, melanoma, and sarcoma.患有癌症、黑色素瘤和肉瘤患者的血清中G、A和M免疫球蛋白的浓度。
J Natl Cancer Inst. 1971 May;46(5):1015-28.
9
Tumor-specific cell-mediated immunity in household contacts of cancer patients.癌症患者家庭接触者中的肿瘤特异性细胞介导免疫。
J Clin Invest. 1975 Mar;55(3):500-13. doi: 10.1172/JCI107956.
10
Role of tumor immunity in ovarian cancer.肿瘤免疫在卵巢癌中的作用。
South Med J. 1977 Oct;70(10):1186-7. doi: 10.1097/00007611-197710000-00009.
Zotero 插件